Study details
Enrolling now
EMPOWER Trial - Carillon Mitral Contour System® for Heart Failure
Cardiac Dimensions, Inc.
NCT IDNCT03142152ClinicalTrials.gov data as of Apr 2026
Target enrollment
300
Study length
about 13 years
Ages
18+
Locations
75 sites in AZ, CA, CO +23
About this study
This trial is testing a new device, the Carillon Mitral Contour System®, to help people with heart failure and functional mitral regurgitation. The goal is to see if this device improves their condition.
Based on ClinicalTrials.gov records.
What participants do
- 1.Guideline Directed Heart Failure Medication
- 2.Use Carillon Mitral Contour System
Primary goalPrimary Safety Objective - Freedom from Major Adverse Events
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low7%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Primary Safety Objective - Freedom from Major Adverse Events
Secondary: Exploratory Secondary Endpoint 1 - Change in Six-Minute Walk Distance, Exploratory Secondary Endpoint 2 - Change in KCCQ
Body systems
Cardiology / Heart